Search research articles
Contact Us
Filters
Showing results (301-310 of 312) with videos related to
Page
of 32
Sort By:
The Journal of Antimicrobial Chemotherapy
|
March 8, 2018
CTX-M ESBL-producing Enterobacteriaceae: estimated prevalence in adults in England in 2014
Cliodna A M McNulty, Donna M Lecky, Li Xu-McCrae, et al.
The Journal of Antimicrobial Chemotherapy
|
December 19, 2017
Prevalence of carbapenem resistance and carbapenemase production among Enterobacteriaceae isolated from urine in the UK: results of the UK infection-Carbapenem Resistance Evaluation Surveillance Trial (iCREST-UK)
Neil Woodford, Li Xu-McCrae, Shazad Mushtaq, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
August 1, 2016
Enhanced surveillance of carbapenemase-producing Gram-negative bacteria to support national and international prevention and control efforts
R Freeman, D Ironmonger, R Puleston, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 13, 2012
Changing epidemiology of Clostridium difficile infection following the introduction of a national ribotyping-based surveillance scheme in England
M H Wilcox, N Shetty, W N Fawley, et al.
The Journal of Hospital Infection
|
September 4, 2018
The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines
Benjamin H Mullish, Mohammed Nabil Quraishi, Jonathan P Segal, et al.
Emerging Microbes & Infections
|
March 19, 2020
Biological characteristics associated with virulence in <i>Clostridioides difficile</i> ribotype 002 in Hong Kong
Ka Yi Kong, Thomas N Y Kwong, Hung Chan, et al.
Gut
|
August 30, 2018
The use of faecal microbiota transplant as treatment for recurrent or refractory <i>Clostridium difficile</i> infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines
Benjamin H Mullish, Mohammed Nabil Quraishi, Jonathan P Segal, et al.
Journal of Clinical Microbiology
|
May 25, 2017
Correction for Cairns et al., "Comparative Genome Analysis and Global Phylogeny of the Toxin Variant Clostridium difficile PCR Ribotype 017 Reveals the Evolution of Two Independent Sublineages"
M D Cairns, M D Preston, C L Hall, et al.
Journal of Clinical Microbiology
|
December 30, 2016
Comparative Genome Analysis and Global Phylogeny of the Toxin Variant Clostridium difficile PCR Ribotype 017 Reveals the Evolution of Two Independent Sublineages
M D Cairns, M D Preston, C L Hall, et al.
The Lancet. Infectious Diseases
|
November 20, 2012
Whole-genome sequencing to delineate Mycobacterium tuberculosis outbreaks: a retrospective observational study
Timothy M Walker, Camilla L C Ip, Ruth H Harrell, et al.
Page
of 32
Search research articles
Search
Showing results (301-310 of 312) with videos related to
Sort By:
Page
of 32
The Journal of Antimicrobial Chemotherapy
|
March 8, 2018
CTX-M ESBL-producing Enterobacteriaceae: estimated prevalence in adults in England in 2014
Cliodna A M McNulty, Donna M Lecky, Li Xu-McCrae, et al.
The Journal of Antimicrobial Chemotherapy
|
December 19, 2017
Prevalence of carbapenem resistance and carbapenemase production among Enterobacteriaceae isolated from urine in the UK: results of the UK infection-Carbapenem Resistance Evaluation Surveillance Trial (iCREST-UK)
Neil Woodford, Li Xu-McCrae, Shazad Mushtaq, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
August 1, 2016
Enhanced surveillance of carbapenemase-producing Gram-negative bacteria to support national and international prevention and control efforts
R Freeman, D Ironmonger, R Puleston, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 13, 2012
Changing epidemiology of Clostridium difficile infection following the introduction of a national ribotyping-based surveillance scheme in England
M H Wilcox, N Shetty, W N Fawley, et al.
The Journal of Hospital Infection
|
September 4, 2018
The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines
Benjamin H Mullish, Mohammed Nabil Quraishi, Jonathan P Segal, et al.
Emerging Microbes & Infections
|
March 19, 2020
Biological characteristics associated with virulence in <i>Clostridioides difficile</i> ribotype 002 in Hong Kong
Ka Yi Kong, Thomas N Y Kwong, Hung Chan, et al.
Gut
|
August 30, 2018
The use of faecal microbiota transplant as treatment for recurrent or refractory <i>Clostridium difficile</i> infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines
Benjamin H Mullish, Mohammed Nabil Quraishi, Jonathan P Segal, et al.
Journal of Clinical Microbiology
|
May 25, 2017
Correction for Cairns et al., "Comparative Genome Analysis and Global Phylogeny of the Toxin Variant Clostridium difficile PCR Ribotype 017 Reveals the Evolution of Two Independent Sublineages"
M D Cairns, M D Preston, C L Hall, et al.
Journal of Clinical Microbiology
|
December 30, 2016
Comparative Genome Analysis and Global Phylogeny of the Toxin Variant Clostridium difficile PCR Ribotype 017 Reveals the Evolution of Two Independent Sublineages
M D Cairns, M D Preston, C L Hall, et al.
The Lancet. Infectious Diseases
|
November 20, 2012
Whole-genome sequencing to delineate Mycobacterium tuberculosis outbreaks: a retrospective observational study
Timothy M Walker, Camilla L C Ip, Ruth H Harrell, et al.
Page
of 32